Infratil Lifts CDC Valuation to A$15bn as Data Centre Pipeline Expands

Infratil Limited ( (IFUUF) ) has issued an update.

Infratil has reported a higher independent valuation for its data centre investment CDC as at 31 March 2026, highlighting the continued build-out of CDC’s capacity pipeline in Australia and New Zealand. The revaluation underscores CDC’s position as a key digital infrastructure platform within Infratil’s portfolio and reflects strong demand for additional capacity at campuses such as Marsden Park and Eastern Creek.

CDC’s equity value rose by A$1 billion over the quarter to A$15 billion, marking a 7.2% gain driven by a larger development pipeline and a A$500 million equity raise that included A$250 million from Infratil. On this basis, the value of Infratil’s 49.72% stake increased by A$500 million to A$7.454 billion, though higher gearing and rising funding costs partly offset valuation gains even as the group secured expanded bank debt capacity and diversified its funding sources.

Independent valuation assumptions show CDC’s enterprise value at just over A$20 billion and incorporate an uplift in the cost of equity to 11.84% to reflect greater leverage associated with accelerated construction. The updated build programme sees operating capacity lifted to 671MW and total pipeline capacity to 2,906MW through FY34, with notable additions at CDC’s Marsden Park and Laverton campuses underscoring a long-term expansion path out to 2040.

More about Infratil Limited

Infratil Limited is a New Zealand-based infrastructure investment company with a portfolio spanning sectors such as digital infrastructure, including a major stake in data centre operator CDC. Through CDC, Infratil is exposed to the fast-growing demand for hyperscale and enterprise data centre capacity across Australia and New Zealand, where CDC is expanding campuses in key markets such as Sydney, Melbourne, Canberra, Perth and Auckland.

For a thorough assessment of IFUUF stock, go to TipRanks’ Stock Analysis page.